NuLife PeptidesCJC-1295
NuLife Peptides' CJC-1295 profile is clean but still thin, with both results from one March 2026 batch. Identity passed, purity sat at 99.6% just over this methodology's cutoff, and fills were modestly high at +4% and +6%.
We investigated who actually operates NuLife Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including NuLife Peptides rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 5 Mar 2026 | Pass | mmbp5hw Tested | lab name | View COA | |||
| 5 Mar 2026 | Pass | 2fymbst Tested | lab name | View COA | |||
About NuLife Peptides test results from Finnrick
NuLife Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 7 peptides and 14 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible NuLife Peptides peptides in this dataset are CJC-1295 (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 14 recent tests.